SFRP1 and central nervous system cancer: This suggestion is further supported by recent data on SFRP1 mRNA levels in glioma patients presented in the REMBRANT (Repository of Molecular Brain Neoplasia Data) and TCGA (The Cancer Genome Atlas) databases.